VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JXN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JXNJackson Financial Inc.
$109.28$7.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJXNQuarterly Financials

Jackson Financial Inc. (JXN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Jackson Financial Inc. (JXN) quarterly income statement — complete revenue, gross profit & net income history

JXN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue2.9B2.09B1.35B-483M3.72B158M2.09B1.2B-359M905M2.59B431M-754M-535M2.97B6.7B2.21B1.69B1.56B244M
Revenue Growth %-22.05%1225.32%-35.55%-140.25%1137.05%-82.54%-19.28%178.42%52.39%269.16%-12.81%-93.57%-134.13%-131.71%90.03%2647.13%-59.48%213.92%--
Medical Costs & Claims2.26B-2.38B977M-1.03B3.4B-543M2.28B563M-1.6B2.43B-1.26B-1.43B949M194M108M2.29B-743M550.6M975M506M
Medical Cost Ratio %77.91%-113.47%72.42%214.29%91.46%-343.67%109.08%46.92%445.96%268.95%-48.48%-331.32%-125.86%-36.26%3.63%34.24%-33.64%32.63%62.3%207.38%
Gross Profit641M4.47B372M552M318M701M-190M637M1.24B-1.53B3.85B1.86B-1.7B-729M2.87B4.41B2.95B1.14B590M-262M
Gross Margin %22.09%213.47%27.58%-114.29%8.54%443.67%-9.08%53.08%-345.96%-168.95%148.48%431.32%225.86%136.26%96.37%65.76%133.64%67.37%37.7%-107.38%
Gross Profit Growth %101.57%537.66%295.79%-13.34%-74.4%145.85%-104.94%-65.73%172.93%-109.74%34.33%-57.83%-157.69%-164.13%385.76%1782.44%-22.32%1409.56%--
Operating Expenses1.04B4.83B300M363M335M321M389M319M339M426M348M394M351M224M341M269M339M388.4M338M276M
OpEx / Revenue %35.87%230.56%22.24%-75.16%9%203.16%18.59%26.58%-94.43%47.07%13.42%91.42%-46.55%-41.87%11.47%4.01%15.35%23.02%21.6%113.11%
Depreciation & Amortization000000000000002M3M3M2.6M4M2M
Combined Ratio %113.78%117.1%94.66%139.13%100.46%-140.51%127.66%73.5%351.53%316.02%-35.06%-239.91%-172.41%-78.13%15.1%38.25%-18.29%55.65%83.9%320.49%
Operating Income-400M-358M72M189M-17M380M-579M318M903M-1.96B3.5B1.47B-2.05B-953M2.52B4.14B2.61B748.3M252M-538M
Operating Margin %-13.78%-17.1%5.34%-39.13%-0.46%240.51%-27.66%26.5%-251.53%-216.02%135.06%339.91%272.41%178.13%84.9%61.75%118.29%44.35%16.1%-220.49%
Operating Income Growth %-2252.94%-194.21%112.44%-40.57%-101.88%119.44%-116.53%-78.29%143.96%-105.14%38.69%-64.61%-178.61%-227.36%901.98%869.33%-27.13%558.52%--
EBITDA-400M-333M97M214M8M405M-554M344M928M-1.92B3.53B1.49B-2.03B-913M2.53B4.14B2.62B750.9M256M-536M
EBITDA Margin %-13.78%-15.9%7.19%-44.31%0.21%256.33%-26.47%28.67%-258.5%-212.15%136.14%346.4%268.7%170.65%84.97%61.79%118.42%44.5%16.36%-219.67%
Interest Expense25M25M25M25M25M25M25M26M25M35M49M28M43M40M29M24M20M18M6.3M7M
Non-Operating Income0-25M-25M-25M-25M-25M-25M-26M-25M-35M-28M-28M-28M-40M-29M-24M-20M-18M-6M-7M
Pretax Income-400M-358M72M189M-17M380M-579M318M903M-1.96B3.5B1.47B-2.05B-953M2.52B4.14B2.61B748.3M252M-538M
Pretax Margin %-13.78%-17.1%5.34%-39.13%-0.46%240.51%-27.66%26.5%-251.53%-216.02%135.06%339.91%272.41%178.13%84.9%61.75%118.29%44.35%16.1%-220.49%
Income Tax20M-172M-19M4M1M22M-113M36M101M-395M712M245M-558M-235M657M845M388M87.3M-16M-54M
Effective Tax Rate %-5%48.04%-26.39%2.12%-5.88%5.79%19.52%11.32%11.18%20.2%20.33%16.72%27.17%24.66%26.02%20.42%14.85%11.67%-6.35%10.04%
Net Income-424M-204M76M179M-24M345M-469M275M795M-1.56B2.77B1.22B-1.5B-710M1.88B3.26B2.19B585.3M206M-540M
Net Margin %-14.61%-9.74%5.63%-37.06%-0.64%218.35%-22.41%22.92%-221.45%-172.27%106.94%282.37%198.54%132.71%63.18%48.68%99.32%34.69%13.16%-221.31%
Net Income Growth %-1666.67%-159.13%116.2%-34.91%-103.02%122.13%-116.91%-77.4%153.11%-119.58%47.58%-62.7%-168.23%-221.31%812.14%704.26%-25.17%673.18%--
EPS (Diluted)-6.24-3.060.922.34-0.484.64-6.373.439.94-19.6433.3514.21-18.11-8.5816.8336.5924.397.002.18-5.72
EPS Growth %-1200%-165.95%114.44%-31.78%-104.83%123.63%-119.1%-75.86%154.89%-128.9%98.16%-61.16%-174.25%-222.57%672.02%739.69%-21.42%503.45%--
EPS (Basic)-6.24-3.070.932.34-0.484.64-6.373.4510.04-19.6433.6614.58-18.11-8.5817.3837.9625.417.002.18-5.72
Diluted Shares Outstanding69.71M70.28M70.28M71.94M73.47M74.42M75.37M77.08M78.87M79.92M82.82M84.75M82.65M83.7M87.9M89.17M89.96M94.47M94.46M94.46M